High-throughput screening for a SARS-CoV-2 frameshifting inhibitor using a cell-free protein synthesis system

被引:0
|
作者
Machida, Kodai [1 ]
Tanaka, Rin [1 ]
Miki, Seraya [1 ]
Noseda, Shotaro [1 ]
Yuasa-Sunagawa, Mayumi [1 ]
Imataka, Hiroaki [1 ]
机构
[1] Univ Hyogo, Grad Sch Engn, Dept Appl Chem, Himeji 6712201, Japan
关键词
cell-free protein synthesis; drug discovery; programmed-1 ribosomal frameshifting; SARS-CoV-2; screening; SARS-CORONAVIRUS; LIGAND; IDENTIFICATION; AGGREGATION;
D O I
10.2144/btn-2023-0102
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Programmed-1 ribosomal frameshifting (-1 PRF) is a translational mechanism adopted by some viruses, including SARS-CoV-2. To find a compound that can inhibit -1 PRF in SARS-CoV-2, we set up a high-throughput screening system using a HeLa cell extract-derived cell-free protein synthesis (CFPS) system. A total of 32,000 compounds were individually incubated with the CFPS system programmed with a -1 PRF-EGFP template. Several compounds were observed to decrease the -1 PRF-driven fluorescence, and one of them had some suppressive effect on -1 PRF of a SARS-CoV-2 genome sequence in transfected cells. Thus the CFPS system can be used as a tool for a high-throughput screening of chemicals.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Development of high-throughput screening system using cell-free protein synthesis system
    Nakano, H
    Yamane, T
    [J]. NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY, 2004, 78 (05): : 483 - 486
  • [2] A bilayer cell-free protein synthesis system for high-throughput screening of gene products
    Sawasaki, T
    Hasegawa, Y
    Tsuchimochi, M
    Kamura, N
    Ogasawara, T
    Kuroita, T
    Endo, Y
    [J]. FEBS LETTERS, 2002, 514 (01) : 102 - 105
  • [3] A cell-free protein synthesis system for high-throughput proteomics
    Sawasaki, T
    Ogasawara, T
    Morishita, R
    Endo, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) : 14652 - 14657
  • [4] SARS-CoV-2 replicon for high-throughput antiviral screening
    Zhang, Qiu-Yan
    Deng, Cheng-Lin
    Liu, Jing
    Li, Jia-Qi
    Zhang, Hong-Qing
    Li, Na
    Zhang, Ya-Nan
    Li, Xiao-Dan
    Zhang, Bo
    Xu, Yi
    Ye, Han-Qing
    [J]. JOURNAL OF GENERAL VIROLOGY, 2021, 102 (05):
  • [5] A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicity
    Shine Varghese Jancy
    Santhik Subhasingh Lupitha
    Aneesh Chandrasekharan
    Shankara Narayanan Varadarajan
    Shijulal Nelson-Sathi
    Roshny Prasad
    Sara Jones
    Sreekumar Easwaran
    Pramod Darvin
    Aswathy Sivasailam
    Thankayyan Retnabai Santhoshkumar
    [J]. Biological Procedures Online, 25
  • [6] A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicity
    Jancy, Shine Varghese
    Lupitha, Santhik Subhasingh
    Chandrasekharan, Aneesh
    Varadarajan, Shankara Narayanan
    Nelson-Sathi, Shijulal
    Prasad, Roshny
    Jones, Sara
    Easwaran, Sreekumar
    Darvin, Pramod
    Sivasailam, Aswathy
    Santhoshkumar, Thankayyan Retnabai
    [J]. BIOLOGICAL PROCEDURES ONLINE, 2023, 25 (01)
  • [7] High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor
    Clyde, Austin
    Galanie, Stephanie
    Kneller, Daniel W.
    Ma, Heng
    Babuji, Yadu
    Blaiszik, Ben
    Brace, Alexander
    Brettin, Thomas
    Chard, Kyle
    Chard, Ryan
    Coates, Leighton
    Foster, Ian
    Hauner, Darin
    Kertesz, Vilmos
    Kumar, Neeraj
    Lee, Hyungro
    Li, Zhuozhao
    Merzky, Andre
    Schmidt, Jurgen G.
    Tan, Li
    Titov, Mikhail
    Trifan, Anda
    Turilli, Matteo
    Van Dam, Hubertus
    Chennubhotla, Srinivas C.
    Jha, Shantenu
    Kovalevsky, Andrey
    Ramanathan, Arvind
    Head, Martha S.
    Stevens, Rick
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (01) : 116 - 128
  • [8] A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
    Mravinacova, Sara
    Jonsson, Malin
    Christ, Wanda
    Klingstrom, Jonas
    Yousef, Jamil
    Hellstrom, Cecilia
    Hedhammar, My
    Havervall, Sebastian
    Thalin, Charlotte
    Pin, Elisa
    Tegel, Hanna
    Nilsson, Peter
    Manberg, Anna
    Hober, Sophia
    [J]. NEW BIOTECHNOLOGY, 2022, 66 : 46 - 52
  • [9] Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
    Tanaka, Tomohisa
    Saito, Akatsuki
    Suzuki, Tatsuya
    Miyamoto, Yoichi
    Takayama, Kazuo
    Okamoto, Toru
    Moriishi, Kohji
    [J]. ANTIVIRAL RESEARCH, 2022, 199
  • [10] SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
    Delgado, Renee
    Vishwakarma, Jyoti
    Moghadasi, Seyed Arad
    Otsuka, Yuka
    Shumate, Justin
    Cuell, Ashley
    Tansiongco, Megan
    Cooley, Christina B.
    Chen, Yanjun
    Dabrowska, Agnieszka
    Basu, Rahul
    Anindita, Paulina Duhita
    Luo, Dahai
    Dosa, Peter I.
    Harki, Daniel A.
    Bannister, Thomas
    Scampavia, Louis
    Spicer, Timothy P.
    Harris, Reuben S.
    [J]. SLAS DISCOVERY, 2024, 29 (06)